Isabelle Karine Giuliani

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Bio-Rad Innovations, Centre National De La Recherche Scientifique, Bio-Rad Europe Gmbh. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Karine Giuliani. Retrieved from https://idiyas.com/inventor/isabelle-karine-giuliani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 28.6

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 28(Granted Patents)

Location History:

Montpellier, FR (2009 - 2011)
Borville, FR (2013)
Garches, FR (2013 - 2022)

Company Filing History:

Centre National De La Recherche Scientifique

Universitè De Montpellier

patents

where one patent can have more than one assignee

Years Active: 2009-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11340239 - BNP (1-32) epitope and antibodies directed against said epitope (2022-05-24),

2. 10495649 - BNP (1-32) epitope and antibodies directed against said epitope (2019-12-03),

3. 9481720 - BNP(1-32) epitope and antibodies directed against said epitope (2016-11-01),

4. 8524459 - Method for the in vitro diagnosis of stroke (2013-09-03),

5. 8486652 - Method for the in vitro diagnosis of stroke (2013-07-16),

6. 8013115 - Use of stabilised synthetic compounds in immunoassay (2011-09-06),

7. 7553937 - Specific antibodies for diagnosing heart failure (2009-06-30),

Title: The Innovative Contributions of Isabelle Karine Giuliani

Introduction

Isabelle Karine Giuliani is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and antibodies. With a total of seven patents to her name, her work has had a considerable impact on medical research and applications.

Latest Patents

Among her latest patents is the invention related to the BNP (1-32) epitope and antibodies directed against said epitope. This invention involves a polypeptide carrying a human BNP(1-32) epitope according to a specific formula. The polypeptide is designed to enhance the specificity and efficacy of ligands that target the FGRKMDR epitope. This innovative approach has the potential to advance therapeutic strategies in cardiovascular medicine.

Career Highlights

Isabelle has worked with notable organizations such as the Centre National de la Recherche Scientifique and Bio-Rad Innovations. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Throughout her career, Isabelle has collaborated with esteemed colleagues, including Francois Yves Rieunier and Sylvie Villard-Saussine. These partnerships have fostered a rich environment for innovation and have led to the successful development of her patented technologies.

Conclusion

Isabelle Karine Giuliani's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence advancements in medical research and applications.

Profile summary based on public USPTO records.